Geoffrey Joyce, University of Southern California Past public ire over high drug prices has recently taken a back seat to a more insidious problem – no drugs at any price. Patients and their providers increasingly face limited or nonexistent supplies of drugs, many of which treat essential conditions such as cancer, heart disease and bacterial infections.